These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5004572)

  • 21. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for administering heparin.
    Thurber CF
    J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heparin treatment of thromboembolic complications].
    Samama M; Kher A; Horellou MH; Conard J
    Agressologie; 1983 Nov; 24(10):495-500. PubMed ID: 6367509
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring heparin therapy.
    Stevens DJ; Latorraca R
    Wis Med J; 1977 Mar; 76(3):33-6. PubMed ID: 842040
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemorrhages during cardiac surgery with extracorporeal circulation].
    Gascon P; Daussy M; Daumet P
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):323-7. PubMed ID: 5618385
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodialysis without heparin. The effect on hemocoagulation parameters].
    Charvát J; Kaslíková J; Bláha J; Spánková H; Mlejnková M; Harosová H; Adamová Z
    Cas Lek Cesk; 1986 Dec; 125(49):1508-10. PubMed ID: 3802141
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of calcium heparinate in anticoagulant therapy].
    Vivien P; Allannic H; Loussouarn J; Turpin J
    Therapie; 1971; 26(1):141-8. PubMed ID: 5554761
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of the intravascular activation of blood clotting. II. Results of the paracoagulation test in patients undergoing open heart surgery, with extracorporeal circulation.
    Palester-Chlebowczyk M; Strzyzewska E; Sitkowski W; Olender A
    Pol Med J; 1972; 11(1):59-66. PubMed ID: 5041003
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic heparinization by subcutaneous route with individualized adjustment of the injected dose and of the time schedule of administration].
    Langer B; Montagnini AL; Kutner JM; Khoury V; Albers MT; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):35-9. PubMed ID: 6484439
    [No Abstract]   [Full Text] [Related]  

  • 35. The whole blood recalcification clotting time. A suggested simple and reliable method for monitoring heparin therapy.
    Fanning JP; Dubeau AM
    J Maine Med Assoc; 1974 Sep; 65(9):211, 3. PubMed ID: 4416580
    [No Abstract]   [Full Text] [Related]  

  • 36. [Surgery under heparin. 3. Incomplete progressive neutralization of heparin at the end of extracorporeal circulation].
    Baille Y; Blanc T; Monties JR; Cohen M; Serra P; Jaquenoud P; Henry E
    Agressologie; 1970; 11(1):87-93. PubMed ID: 5423762
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet factor release following heparin administration and during extracorporeal circulation.
    Flicker W; Milthorpe BK; Schindhelm K; Odell RA; McPherson J; Farrell PC
    Trans Am Soc Artif Intern Organs; 1982; 28():431-6. PubMed ID: 6219490
    [No Abstract]   [Full Text] [Related]  

  • 38. Rationale and usefulness of heparinization: an overview.
    Palmer RL
    Tex Med; 1977 May; 73(5):68-72. PubMed ID: 860281
    [No Abstract]   [Full Text] [Related]  

  • 39. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparinisation during haemodialysis.
    Patel R; Vertes V
    N Z Med J; 1967 Jul; 66(419):471-2. PubMed ID: 5233367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.